Cantata’s West Coast Premiere At UCLA To Benefit Israel Research Cancer Fund
The West Coast premiere of The Long Bright at 7:30 p.m., Thursday, March 11, at UCLA’s Royce Hall will be a concert of hope benefiting the Israel Cancer Research Fund.
The ICRF is a “non-bricks and mortar” foundation that has raised more than $40 million since its inception in 1975, directly supporting the most innovative and effective research scientists who share their groundbreaking knowledge globally.
Some of the work ICRF has funded includes discoveries that have garnered two Nobel Prizes. In particular, one of the greatest revelations of this century has been the discovery by ICRF grant researchers of the p53 gene responsible for tumor suppression.
ICRF scientists have also received five Israel Prizes, two Albert Lasker awards, a Wolf Prize, and represent a key role in the discovery of the drugs Gleevec, Doxil and Velcade, utilized in the treatment of leukemia, breast cancer, and multiple myeloma respectively.
The Long Bright is a tribute chronicling Anni Baker Wolman’s struggle with breast cancer based on a poem of the same name by her husband David, and set to Andrea Clearfield’s music.
The cantata will be performed by the Los Angeles Jewish Symphony under the direction of Dr. Noreen Green, with Grammy-award winning Israeli soprano Hila Plitmann and vocal accompaniment by the multi-generational, inter-faith women’s choir Kol Isha.
The event is chaired by Barbara Lazaroff, and “will prove to be an amazing and uplifting evening which through the brilliant work of the ICRF will help present and future generations,” she said.
Pre- and post-concert events are included in sponsorship levels from $100.000 to $2.500. Sponsorship of a minimum $500 includes the post party.
For sponsorship and advertising information, call 323- 651-1200.
To order tickets directly, call Royce Hall, 310-825-2101.
For more information, visit www.longbright.org.